TELUS Corp
T
Power Corporation of Canada
POW
BCE Inc
BCE
4
Emera Inc
EMA
5
Choice Properties Real Estate Investment Trust
CHP.UN
Quest PharmaTech Inc is a Canadian-based pharmaceutical company developing targeted cancer therapy with its lead product MAb AR9.6, under development for a novel target- truncated O-glycans on MUC16 discovered at the University of Nebraska Medical Center. The company is also developing products utilizing proprietary transdermal delivery technologies with a focus on dermatology and wound healing applications.